Substance Abuse/Drugs

Substance use disorders among pregnant women and the number of infants born with prenatal substance exposure continues to rise. To address this, the Child Abuse Prevention and Treatment Act (CAPTA) requires that states develop Plans of Safe Care and have policies and procedures to address the needs of this population. Presenters will briefly discuss the CAPTA requirements, some best practices, and examine the implications for active efforts and compliance with the Indian Child Welfare Act (ICWA).

This webinar will explore successful examples of law enforcement/community coalitions that have produced positive outcomes. Examples of positive outcomes include increasing public awareness of opioid risks, reaching youth with critical messages regarding fentanyl, responding to fatal overdoses, reducing stigma associated with Substance Use Disorder (SUD), and promoting links to effective treatment. The webinar will also discuss multidisciplinary and community policing partnerships that helped lead to program success.

Emerging adults are more likely to be arrested, be incarcerated, and to recidivate after release. Join the Juvenile Unit/Juvenile Alternative Resolution Program at the Office of Suffolk County, New York District Attorney Rachael Rollins, the Committee for Public Counsel Services, the brain-science experts at the Massachusetts General Hospital Center for Law, Brain & Behavior, and the staff and youth at More Than Words to learn why and discuss how we can reverse this trend.

The dates for the series are as follows:

Peer support specialists offer unique skills that can drastically enhance services using their lived experience to support those with mental health and substance use conditions. Their shared experiences can help to bridge interpersonal and instrumental barriers to accomplishing the health and wellness goals of those in recovery.

The recent rise in the illicit trade of highly toxic synthetic drugs such as fentanyl has introduced a new set of potential health hazards to the forensic laboratory. Proper management of this employee health risk can be extremely challenging considering that there are currently no established regulatory guidelines and few published studies on forensic laboratory drug exposures.

This webinar will highlight the experiences, efforts, and needs of first responder agencies relative to exposure to traumatic stressors specific to the opioid crisis.

Using information gathered from interviews with mid- to high-level supervisors from several local law enforcement agencies, as well as fire department and emergency medical services staff, speakers will discuss insights into the awareness of this work’s impact on first responders, the measures agencies have taken to minimize negative effects on staff, and products or tools needed to advance these efforts.

The Sexual Assault Kit Initiative (SAKI) Training and Technical Assistance (TTA) Team is continuing their new interview series, Meet the SAKI Experts! This series of brief interviews will highlight SAKI TTA’s partners and consultants and their roles on the SAKI project. During each event, a member of the SAKI TTA Team will conduct a virtual interview with the featured subject matter expert.

Join BJA's Comprehensive Opioid, Stimulant, and Substance Abuse Program (COSSAP) for their webinar “Engaging Clients in Treatment: Combining MRT with MAT for Opioid Use Disorder.”

This webinar will provide a brief overview of the Maricopa County, Arizona Attorney’s Office (MCAO) Sexual Assault Kit Initiative (SAKI) project and how it used funding to provide advanced/additional DNA testing to the 25 police agencies within its prosecutorial jurisdiction. SAKI Site Coordinator Cesar Tirado will discuss the procurement process used to identify vendor labs, how requesting police agencies obtain funds, and some of the unique challenges encountered as part of this funding opportunity.  

Join the National Police Foundation, Major Cities Chiefs Association, and the Police Executive Research Forum for a COVID-19 briefing for law enforcement executives on Thursday, March 19, 2020 from 1:00 to 2:00 p.m. ET. The briefing will be conducted by representatives from the Centers for Disease Control’s (CDC) National Institute for Occupational Safety and Health (NIOSH), and Public Health Service (PHS).